Reuters logo
BRIEF-Jazz Pharma announces $500 mln offering of 1.50 pct exchangeable senior notes due 2024
August 18, 2017 / 11:11 AM / a month ago

BRIEF-Jazz Pharma announces $500 mln offering of 1.50 pct exchangeable senior notes due 2024

Aug 18 (Reuters) - Jazz Pharmaceuticals Plc

* Jazz Pharmaceuticals Plc - ‍offering of $500 million aggregate principal amount of 1.50% exchangeable senior notes due 2024​

* Jazz Pharmaceuticals - ‍ intends to use net proceeds from offering to repay portion of $500 million of outstanding borrowings under revolving credit facility​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below